Total Payments
$2,471
2023 Payments
$295.67
Companies
31
Transactions
113
Medicare Patients
5,379
Medicare Billing
$968,552
Payment Breakdown by Category
Food & Beverage$2,471 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,471 | 113 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $531.21 | 15 | $0 (2021) |
| Amgen Inc. | $371.29 | 15 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $192.94 | 17 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $109.26 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $94.53 | 4 | $0 (2023) |
| Novo Nordisk Inc | $86.06 | 4 | $0 (2021) |
| PFIZER INC. | $84.02 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $83.88 | 4 | $0 (2023) |
| Janssen Biotech, Inc. | $83.17 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $73.74 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $295.67 | 11 | GlaxoSmithKline, LLC. ($83.88) |
| 2021 | $102.80 | 5 | Novo Nordisk Inc ($24.95) |
| 2020 | $122.10 | 5 | Amgen Inc. ($32.05) |
| 2019 | $740.24 | 38 | Otsuka America Pharmaceutical, Inc. ($208.91) |
| 2018 | $508.76 | 24 | Amgen Inc. ($125.24) |
| 2017 | $700.95 | 30 | Otsuka America Pharmaceutical, Inc. ($213.23) |
All Payment Transactions
113 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.21 | General |
| Category: Immunology | ||||||
| 08/16/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Immunology | ||||||
| 08/03/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | CYLTEZO (Drug) | Food and Beverage | In-kind items and services | $34.43 | General |
| Category: CNS | ||||||
| 05/25/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Immunology | ||||||
| 05/23/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: Biosimilars | ||||||
| 04/19/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $35.58 | General |
| Category: Immunology | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $34.13 | General |
| Category: Immunology | ||||||
| 01/31/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: IMMUNOLOGY | ||||||
| 01/06/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2021 | DePuy Synthes Sales Inc. | MONOVISC (Device) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Sports Early Intervention | ||||||
| 07/19/2021 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEPHROLOGY | ||||||
| 06/29/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Obesity | ||||||
| 06/17/2021 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: OBESITY | ||||||
| 03/25/2021 | ARBOR PHARMACEUTICALS, INC. | Horizant (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Sleep | ||||||
| 03/11/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: Nephrology | ||||||
| 03/02/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Obesity | ||||||
| 02/12/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: NEPHROLOGY | ||||||
| 02/05/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/08/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: Hyperparathyroidism | ||||||
| 12/03/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: Hyperparathyroidism | ||||||
| 12/01/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $5.71 | General |
| Category: Hyperparathyroidism | ||||||
| 11/21/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Hyperparathyroidism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 376 | 595 | $563,426 | $91,628 |
| 2022 | 17 | 1,178 | 1,889 | $1.5M | $257,230 |
| 2021 | 20 | 1,789 | 2,903 | $968,963 | $331,375 |
| 2020 | 20 | 2,036 | 3,151 | $430,630 | $288,319 |
Total Patients
5,379
Total Services
8,538
Medicare Billing
$968,552
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 46 | 312 | $285,926 | $96,959 | 33.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 325 | 549 | $201,015 | $58,093 | 28.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 213 | 213 | $80,910 | $31,230 | 38.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 246 | 341 | $75,510 | $23,215 | 30.7% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 38 | 83 | $74,355 | $21,383 | 28.8% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 290 | 474 | $30,520 | $19,455 | 63.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 101 | 109 | $62,817 | $16,994 | 27.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 50 | 261 | $31,938 | $16,044 | 50.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 78 | 78 | $44,034 | $14,498 | 32.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 92 | $15,187 | $8,129 | 53.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 42 | $12,406 | $7,195 | 58.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 87 | 87 | $24,820 | $5,604 | 22.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 51 | 60 | $7,276 | $4,230 | 58.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 16 | 16 | $4,690 | $1,997 | 42.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 91 | 91 | $5,855 | $1,746 | 29.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 14 | 14 | $4,116 | $1,627 | 39.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 16 | 16 | $2,847 | $1,593 | 55.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 13 | 14 | $1,786 | $565.06 | 31.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 24 | 24 | $1,140 | $459.87 | 40.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 26 | 27 | $1,815 | $358.02 | 19.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 45 | 336 | $134,400 | $83,349 | 62.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 296 | 431 | $53,875 | $36,341 | 67.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 349 | 692 | $38,100 | $27,082 | 71.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 166 | 166 | $24,900 | $21,366 | 85.8% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 37 | 83 | $29,050 | $17,302 | 59.6% |
About Dr. Earl Gordon, M.D
Dr. Earl Gordon, M.D is a Nephrology healthcare provider based in Santa Monica, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053534925.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Earl Gordon, M.D has received a total of $2,471 in payments from pharmaceutical and medical device companies, with $295.67 received in 2023. These payments were reported across 113 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($2,471).
As a Medicare-enrolled provider, Gordon has provided services to 5,379 Medicare beneficiaries, totaling 8,538 services with total Medicare billing of $968,552. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Santa Monica, CA
- Active Since 04/10/2007
- Last Updated 11/21/2022
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1053534925
Products in Payments
- JYNARQUE (Drug) $317.98
- SAMSCA (Drug) $213.23
- Rayaldee (Drug) $192.94
- Parsabiv (Biological) $164.89
- Prolia (Biological) $90.51
- BENLYSTA (Biological) $83.88
- TREMFYA (Drug) $83.17
- LOKELMA (Drug) $73.74
- Saxenda (Drug) $68.51
- Uloric (Drug) $68.02
- ACTHAR (Biological) $63.91
- KRYSTEXXA (Drug) $60.52
- JARDIANCE (Drug) $60.10
- XARELTO (Drug) $57.45
- JANUVIA (Drug) $54.64
- Auryxia (Drug) $47.18
- RETACRIT (Biological) $46.87
- Vascepa (Drug) $41.23
- Edarbi (Drug) $40.34
- ASMANEX (Drug) $37.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Santa Monica
Dr. Connie Rhee, M.d, M.D
Nephrology — Payments: $99,698
Nephrology $99,698
Reza Khorsan, M.d, M.D
Nephrology — Payments: $6,844
Nephrology $6,844
Nasimeh Yazdani, M.d, M.D
Nephrology — Payments: $3,461
Nephrology $3,461
Fawad Zafar-Khan, Md, MD
Nephrology — Payments: $2,129
Nephrology $2,129
Ying Hui Luu, M.d, M.D
Nephrology — Payments: $716.35
Nephrology $716.35
Mark Nachman, Md, MD
Nephrology — Payments: $165.28
Nephrology $165.28